Nat Rev Neurol. 2012 Apr 10;8(5):250-1. doi: 10.1038/nrneurol.2012.67.
The success of clinical trials in Huntington disease (HD) will depend to a large degree on the quality of the outcome measures. Using data from the TRACK-HD study, a recent publication proposes a battery of assessments that could be used as outcomes in future clinical trials in patients with early HD.
亨廷顿病（HD）临床试验的成功在很大程度上取决于结局测量的质量。利用 TRACK-HD 研究的数据，最近的一篇出版物提出了一系列评估方法，这些方法可以作为早期 HD 患者未来临床试验的结局指标。
